The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma

Annals of the New York Academy of Sciences

Volumn 795, Issue , 1996, Pages 310-318

  Rook, Alain H ^a,e   Kubin, Marek ^b   Fox, Floyd E ^a   Niu, Zhutian ^a   Cassin, Maureen ^a   Vowels, Benjamin R ^a   Gottleib, Scott L ^a   Vonderheid, Eric C ^c   Lessin, Stuart R ^c,d   Trinchieri, Giorgio ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; RECOMBINANT INTERLEUKIN 12;

CELL CULTURE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; ERYTHRODERMA; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MONONUCLEAR CELL; SEZARY SYNDROME; SKIN DEFECT; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 17344388275     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52680.x     Document Type: Conference Paper

References (26)

1. EDELSON, R. L. 1980. Cutaneous T cell lymphoma: Mycosis fungoides, Sezary syndrome, and other variants. J. Am. Acad. Dermatol. 2: 89-106.
2. HAYNES, B. F., P. BUNN, D. MANN & C. THOMAS. 1981. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. J. Clin. Invest. 67: 523-530.
3. WEISS, L., E. Hu, G. WOOD, C. MOULDS, M. L. CLEARY, R. WARNKE & J. SKLAR. 1985. Clonal rearrangement of T cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N. Engl. J. Med. 313: 539-544.
4. NICKOLOFF, B. J., C. E. M. GRIFFITHS, O. BAADSGAARD, J. J. VOORHEES, C. A. HANSON, & K. D. COOPER. 1989. JAMA 261: 2217-2221.
5. MURPHY, G. F. 1988. Cutaneous T cell lymphoma. Adv. Pathol. 1: 131-156.
6. ROOK, A. H., B. R. VOWELS, C. JAWORSKY, A. SINGH & S. R. LESSIN. 1993. The immunopathogenesis of cutaneous T cell lymphoma: Abnormal cytokine production by Sezary T cells. Arch Dermatol. 129: 486-489.
7. HEALD, P. W. & R. L. EDELSON. 1993. Lymphoma, pseudolymphoma, and related conditions. In Dermatology in General Medicine. 4th edit. T. B. Fitzpatrick, A. Z. Eisen, K. Wolff, I. M. Freedberg & K. F. Austen, Eds.: 1285-1307. McGraw-Hill. New York.
8. VOWELS, B. R., M. CASSIN, E. C. VONDERHEID & A. H. ROOK. 1992. Aberrant cytokine production by Sezary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells. J. Invest. Dermatol. 99: 90-94.
9. VOWELS, B. R., S. R. LESSIN, M. CASSIN, C. JAWORSKY, B. BENOIT, J. T. WOLFE & A. H. ROOK. 1994. Th2 cytokine expression in skin in cutaneous T cell lymphoma. J. Invest. Dermatol. In press.
10. VOWELS, B. R., S. R. LESSIN, M. CASSIN. B. M. BENOIT & A. H. ROOK. 1993. Normalization of cytokine secretion patterns and immune function following disappearance of malignant clone from the peripheral blood of a Sezary syndrome patient. J. Invest. Dermatol. 100: 556.
11. CHAN, S. H., B. PERUSSIA, J. W. GUPTA, M. KOBAYASHI, M. POSPISIL, H. A. YOUNG, S. F. WOLF, D. YOUNG & G. TRINCHIERI. 1991. Induction of IFN γ production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869-879.
12. SYPEK, J. P., C. L. CHUNG, S. E. H. MAYOR, J. M. SUBRAMANYAM, S. J. GOLDMAN, D. S. SIEBURTH, S. F. WOLF & R. G. SCHAUB. 1993. Resolution of cutaneous leishmaniasis: Interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177: 1797-1802.
13. AFONSO, L. C. C., T. M. SCHARTON, L. Q. VIEIRA, M. WYSOCKA, G. TRINCHIERI & P. SCOTT. 1993. IL-12 functions as an effective adjuvant in a vaccine against Leishmania major by directing the development of leishmanial specific CD4+ Thl cells. Science 263: 235-237.
14. KOBAYASHI, M., L. FITZ, R. M. HEWICK, S. C. CLARK, S. CHAN, R. LOUDON, F. SHERMAN, B. PERUSSIA & G. TRINCHIERI. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-846.
15. MEHROTRA, P. T., D. Wu, J. A. CRIM, H. S. MOSTOWSKI & J. P. SIEGAL. 1993. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J. Immunol. 151: 2444-2452.
16. DUMMER, R., O. KOHL, J. GILLESSEN, M. KAGI & G. BURG. 1993. Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T cell lymphoma: Reduced proliferation and preferential secretion of a T helper 2 like cytokine pattern on stimulation. Arch. Dermatol. 129: 433-436.
17. D'ANDREA, A., M. ASTE-AMEZAGA, N. M. VALIANTE, X. MA, M. KUBIN & G. TRINCHIERI. 1993. lnterleukin-10 inhibits human lymphocyte IFN y production by suppressing natural killer cell stimulatory factor/interleukin-12 synthesis in accessory cells. J. Exp. Med. 178: 1041-1048.
18. WOOD, N. L., E. N. KITCES & W. K. BLAYLOCK. 1990. Depressed lymphokine activated killer cell activity in mycosis fungoides. Arch. Dermatol. 126: 907-913.
19. DOHERTY, T. M., R. KASTELEIN, S. MENON, S. ANDRADE & R. L. COFFMAN. 1993. Modulation of murine macrophage function by IL-13. J. Immunol. 151: 7151-7160.
20. ROOK, A. H., M. B. PRYSTOWSKY, M. CASSIN, M. BOUFAL & S. R. LESSIN. 1991. Combined therapy of the Sezary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa: Clinical, molecular and immunologie observations. Arch. Dermatol. 127: 1535-1540.
21. BERGER, C., VV. Liu, P. HEALD, I. CHRISTENSEN & R. EDELSON. 1994. Antitumor response in cutaneous T cell lymphoma. J. Invest. Dermatol. 102: 566.
22. MANETTI, R., P. PARRONCHI, M. G. GIUDIZI, M-P. PICCINNI, E. MAGGI, G. TRINCHIERI & S. ROMAGNANI. 1993. Natural killer cell stimulatory factor (IL-12) induces Th1type specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177: 1199-1204.
23. THOMSEN, K., L. MOLIN & G. VOLDEN. 1984. 13-cis Retinoic acid effective in mycosis fungoides. Acta Derm. Venereol. 64: 563-566.
24. KNOBLER, R. M., F. TRAUTINGER & T. RADASZKIEWICZ. 1991. Treatment of cutaneous T-cell lymphoma with a combination of low-dose interferon alfa 2b and retinoids. J. Am. Acad. Dermatol. 24: 247-251.
25. BRUNDA, M. J., L. LUISTRO, R. R. WARRIER, R. B. WRIGHT, B. R. HUBBARD, M. MURPHY, S. F. WOLF, & M. K. GATELY. 1993. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J. Exp. Med. 178: 1223-1230.
26. SAUSVILLE, E. A., R. L. EDDY, R. W. MAKUCH, A. B. FISCHMANN, G. P. SCHECHTER, M. MATTHEWS, E. GLATSTEIN, D. C. IHDE, F. KAYE, S. R. VEACH, R. PHELPS, T. O'CoNNER, J. B. TREPEL, J. D. COTELINGAM, A. F. GAZDAR, J. D. MINNA & P. BUNN. 1988. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome. Definition of three distinctive prognostic groups. Ann. Intern. Med. 109: 372-382.